Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-03-04, Stock:LLY, The news for the past five days is as follows:
2019-02-25: NEWS1: The Zacks Analyst Blog Highlights: Walmart, Pfizer, Eli Lilly, Merck and Microsoft.NEWS2: The Zacks Analyst Blog Highlights: Walmart, Pfizer, Eli Lilly, Merck and Microsoft.NEWS3: Better Buy: Eli Lilly vs. Johnson & Johnson.NEWS4: Better Buy: Eli Lilly vs. Johnson & Johnson.NEWS5: The Zacks Analyst Blog Highlights: Walmart, Pfizer, Eli Lilly, Merck and Microsoft.NEWS6: Better Buy: Eli Lilly vs. Johnson & Johnson.
2019-02-26: NEWS1: Corcept (CORT) Q4 Earnings Beat Estimates, Revenues In Line.NEWS2: Corcept (CORT) Q4 Earnings Beat Estimates, Revenues In Line.NEWS3: Corcept (CORT) Q4 Earnings Beat Estimates, Revenues In Line.NEWS4: 5 Companies Hit 52-Week Highs.NEWS5: Better Buy: GlaxoSmithKline vs. Eli Lilly.NEWS6: Better Buy: GlaxoSmithKline vs. Eli Lilly.NEWS7: Better Buy: GlaxoSmithKline vs. Eli Lilly.
2019-02-27: NEWS1: Notable Wednesday Option Activity: FDS, LLY, MGPI.NEWS2: Notable Wednesday Option Activity: FDS, LLY, MGPI.NEWS3: Roche Holdings to Acquire Spark Therapeutics.
2019-02-28: NEWS1: Cramer: I'm kicking myself for not recommending these stocks.NEWS2: Cramer: I'm kicking myself for not recommending these stocks.NEWS3: Aduro (ADRO) Q4 Earnings and Revenues Fall Shy of Estimates.NEWS4: Aduro (ADRO) Q4 Earnings and Revenues Fall Shy of Estimates.NEWS5: Aduro (ADRO) Q4 Earnings and Revenues Fall Shy of Estimates.NEWS6: What’s Expected for AstraZeneca’s or Eli Lilly’s EPS Growth.NEWS7: Woburn's Abpro strengthens Chinese ties with immuno-oncology deal.NEWS8: Drug Price Debate: is Legislation Necessary?.NEWS9: Will AstraZeneca or Eli Lilly Report More Revenue Growth?.NEWS10: United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates.NEWS11: United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates.NEWS12: Analysts’ Recommendations for AstraZeneca and Eli Lilly.NEWS13: United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates.
2019-03-01: NEWS1: Market high stocks: 6 trades.NEWS2: Radius (RDUS) Posts Narrower Q4 Loss on Robust Tymlos Sales.NEWS3: Radius (RDUS) Posts Narrower Q4 Loss on Robust Tymlos Sales.NEWS4: 5 Pharmaceutical Stocks With Big Moats and Bridges.NEWS5: 5 Pharmaceutical Stocks With Big Moats and Bridges.NEWS6: Radius (RDUS) Posts Narrower Q4 Loss on Robust Tymlos Sales.NEWS7: 3 Big Stock Charts for Friday: Eli Lilly, Centene and LKQ Corporation.NEWS8: 3 Big Stock Charts for Friday: Eli Lilly, Centene and LKQ Corporation.NEWS9: MTUM, JNJ, LLY, KO: ETF Inflow Alert.NEWS10: MTUM, JNJ, LLY, KO: ETF Inflow Alert.NEWS11: A Look at AstraZeneca’s and Eli Lilly’s Tax and Debt.NEWS12: Nektar Therapeutics (NKTR) Q4 2018 Earnings Conference Call Transcript.NEWS13: Comparing AstraZeneca’s and Eli Lilly’s Dividends.NEWS14: The Daily Biotech Pulse: Puma Biotech Earnings, Mersana Offering, Orphan Drug Designation For Ascendis.NEWS15: 3 Big Stock Charts for Friday: Eli Lilly, Centene and LKQ Corporation.NEWS16: AstraZeneca or Eli Lilly: Which Is Controlling Expenses Better?.NEWS17: Lilly to Present Data Demonstrating Continued Scientific Advancements in Broad Dermatology Portfolio at AAD Annual Meeting.

Answer: Decrease